Hartmann, Wolfgang
University Hospital Münster
6 papers on CoChatORCID 0000-0002-7609-5021
Most cited papers
- Verified
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
Kailayangiri, S., Altvater, B., Spurny, C., Jamitzky, S., Schelhaas, S., Jacobs, A. H., Wiek, C., Roellecke, K., Hanenberg, H., Hartmann, W., et al. (2017) · OncoImmunology
Immune Cell Function and InteractionCAR-T cell therapy research
Cited by 104
- Verified
Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients
Michels, S., Scheel, A. H., Scheffler, M., Schultheis, A. M., Gautschi, O., Aebersold, F., Diebold, J., Pall, G., Rothschild, S., Bubendorf, L., et al. (2016) · Journal of Thoracic Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 91
- Verified
Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma
Krumbholz, M., Eiblwieser, J., Ranft, A., Zierk, J., Schmidkonz, C., Stütz, A. M., Peneder, P., Tomazou, E. M., Agaimy, A., Bäuerle, T., et al. (2021) · Clinical Cancer Research
Sarcoma Diagnosis and TreatmentCancer Genomics and Diagnostics
Cited by 39
- Verified
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
Isfort, I., Elges, S., Cyra, M., Berthold, R., Renner, M., Mechtersheimer, G., Åman, P., Larsson, O., Ratner, N., Hafner, S., et al. (2019) · Scientific Reports
Hippo pathway signaling and YAP/TAZSarcoma Diagnosis and Treatment
Cited by 35
- Verified
Requirement for YAP1 signaling in myxoid liposarcoma
Trautmann, M., Cheng, Y., Jensen, P., Azoitei, N., Brunner, I., Hüllein, J., Slabicki, M., Isfort, I., Cyra, M., Berthold, R., et al. (2019) · EMBO Molecular Medicine
Hippo pathway signaling and YAP/TAZSarcoma Diagnosis and Treatment
Cited by 32
- Verified
Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA
Schmidkonz, C., Krumbholz, M., Atzinger, A., Cordes, M., Goetz, T. I., Prante, O., Ritt, P., Schaefer, C., Agaimy, A., Hartmann, W., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging
Sarcoma Diagnosis and TreatmentMedical Imaging Techniques and Applications
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free